Graham Lidgard
Corporate Officer/Principal bei EXACT SCIENCES CORPORATION
Profil
Graham Peter Lidgard gründete Matritech, Inc. Dr. Lidgard ist Chief Science Officer, SVP-Research & Development bei EXACT Sciences Corp. In seiner früheren Laufbahn war er Senior Vice President-Research & Development bei Ngen, Inc. und Vice President-Research & Development von Gen-Probe, Inc. sowie Vice President-Product Development bei Matritech, Inc. und Vice President-Product Development bei Ciba Corning Diagnostics Corp. Dr. Lidgard erhielt einen Bachelor-Abschluss und einen Doktortitel von der University of Manchester.
Aktive Positionen von Graham Lidgard
Unternehmen | Position | Beginn |
---|---|---|
EXACT SCIENCES CORPORATION | Corporate Officer/Principal | 01.04.2021 |
Ehemalige bekannte Positionen von Graham Lidgard
Unternehmen | Position | Ende |
---|---|---|
NGEN INC | Chief Tech/Sci/R&D Officer | 10.08.2009 |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01.06.2002 |
NANOGEN INC | Chief Tech/Sci/R&D Officer | - |
Ciba Corning Diagnostics Corp. | Corporate Officer/Principal | - |
Matritech, Inc.
Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services | Founder | - |
Ausbildung von Graham Lidgard
The University of Manchester | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
EXACT SCIENCES CORPORATION | Health Technology |
Private Unternehmen | 5 |
---|---|
Matritech, Inc.
Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services | Health Technology |
Ngen, Inc.
Ngen, Inc. Medical SpecialtiesHealth Technology Ngen, Inc. advanced diagnostics provides physicians and patients worldwide with sophisticated information to predict, diagnose and treat disease. Research and clinical reference labs use the highly accurate and reliable NanoChip(R) Molecular Biology Workstation, NanoChip(R) Electronic Microarray and broad suite of analyte specific reagents to develop diagnostic tests for variety of diseases. Nanogen also offers a broad portfolio of patented nucleic acids chemistries and molecular tools that accelerate genomic analysis and are compatible with many systems. The SynX subsidiary offers a line of point-of-care diagnostic tests and is building expertise in cardiac related health conditions. Nanogen's ten years of pioneering research involving nanotechnology may also have future applications in medical diagnostics, biowarfare and other industries. The company is headquartered in San Diego, CA | Health Technology |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
Ciba Corning Diagnostics Corp. | |
NANOGEN INC |